1ABBV:BIT
AbbVie Common Stock
230,10 €
arrow_downward
-0,60%(-1,40) 1D
2-окт., 17:26:00 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
News stories
From web sources and news partners
ad-hoc-news.de
·
3 саат мурун
AbbVie stock sits 3.06 percent below its 52-week high
Kalkine Media
·
7 саат мурун
What Does AbbVie's (NYSE:ABBV) Drug-Pricing Deal Mean for the Stock?
The Motley Fool
·
14 саат мурун
AbbVie vs. Novo Nordisk: Which Healthcare Stock Is a Better Buy in 2026?
Investing.com UK
·
17 саат мурун
AbbVie reports positive Crohn’s disease trial results for Skyrizi By Investing.com
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia